Stay updated on Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP.
Sign up to get notified when there's something new on the Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP. page.

Latest updates to the Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP. page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new information about Retinitis Pigmentosa (RP) and a new version revision, while significant details regarding a study on QLT091001 and its criteria have been removed.SummaryDifference18%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP.
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP. page.